Tempest Therapeutics TPST
NASDAQ TPST
$1.07 +0.05 (+4.90%)
As of: Aug 21, 2026 · 12:43 PM EDT

Tempest Therapeutics (TPST) EBT Margin (QoQ) (2015 - 2018)

Tempest Therapeutics (TPST) EBT Margin (QoQ) (2015 - 2018) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.71 Bn 131.86 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.55 Bn 78.55 Bn 3.93 Bn
3 Argenx Se 65.26 Bn 60.07 Bn 1.37 Bn
4 Moderna 59.81 Bn 54.67 Bn 52.00 Mn
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.87 Bn 28.56 Bn 992.69 Mn
7 BioNTech SE 28.13 Bn 9.74 Bn 668.28 Mn
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn
9 Royalty Pharma 27.31 Bn 26.47 Bn -
10 Tempest Therapeutics 4.44 Mn 3.64 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2018 -81,558.00
Jun 30, 2018 149,012.00
Mar 31, 2018 -166,593.00
Dec 31, 2017 737,308.00
Sep 30, 2017 492,738.00
Jun 30, 2017 199,405.00
Mar 31, 2017 -490,213.00
Dec 31, 2016 -898,076.00
Sep 30, 2016 5,220.00
Jun 30, 2016 505,349.00
Mar 31, 2016 -177,748.00
Dec 31, 2015 1.08 Mn
Sep 30, 2015 3.44 Mn
Jun 30, 2015 5.64 Mn